Latest & Local News

Put text on photo, Blur faces in photos,
Image editing and more...

Gilead news

‘Handmaid’s Tale’ Limps to the Finish Line - Book and Film Globe

‘Handmaid’s Tale’ Limps to the Finish Line Book and Film Globe

Published on 23 May 2025 | 5:37 pm

Gilead Sciences (NasdaqGS:GILD) Announces Promising Phase 3 Results For Trodelvy In Breast Cancer - simplywall.st

Gilead Sciences (NasdaqGS:GILD) Announces Promising Phase 3 Results For Trodelvy In Breast Cancer simplywall.st

Published on 23 May 2025 | 5:32 pm

Gilead (GILD) to Acquire HOOK for $10 million - Yahoo Finance

Gilead (GILD) to Acquire HOOK for $10 million Yahoo Finance

Published on 23 May 2025 | 2:42 pm

Gilead Sciences (GILD) Achieves Key Trial Milestone with Trodelv - GuruFocus

Gilead Sciences (GILD) Achieves Key Trial Milestone with Trodelv GuruFocus

Published on 23 May 2025 | 2:18 pm

After Keytruda combo win, Gilead's Trodelvy meets the mark in solo breast cancer trial - Fierce Pharma

After Keytruda combo win, Gilead's Trodelvy meets the mark in solo breast cancer trial Fierce Pharma

Published on 23 May 2025 | 2:10 pm

Gilead (GILD) Announces Promising Results from Trodelvy Study | - GuruFocus

Gilead (GILD) Announces Promising Results from Trodelvy Study | GuruFocus

Published on 23 May 2025 | 1:25 pm

Gilead posts trial win for Trodelvy in breast cancer (GILD) - Seeking Alpha

Gilead posts trial win for Trodelvy in breast cancer (GILD) Seeking Alpha

Published on 23 May 2025 | 1:07 pm

Gilead Sciences (GILD) announces positive data from Phase 3 Trodelvy study - StreetInsider

Gilead Sciences (GILD) announces positive data from Phase 3 Trodelvy study StreetInsider

Published on 23 May 2025 | 12:34 pm

ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors - Business Wire

ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors Business Wire

Published on 23 May 2025 | 12:30 pm

Gilead records another pivotal study success for Trodelvy in first-line TNBC - FirstWord Pharma

Gilead records another pivotal study success for Trodelvy in first-line TNBC FirstWord Pharma

Published on 23 May 2025 | 10:17 am

Yuhan Corporation signs 88.8 billion won contract to supply Gilead with HIV APIs - Chosunbiz

Yuhan Corporation signs 88.8 billion won contract to supply Gilead with HIV APIs Chosunbiz

Published on 23 May 2025 | 7:20 am

AbbVie, Gilead, UCB collect Korea nods for June reimbursement lineup - koreabiomed.com

AbbVie, Gilead, UCB collect Korea nods for June reimbursement lineup koreabiomed.com

Published on 23 May 2025 | 6:49 am

"Wicked, Godless Men": Aunt Lydia's Handmaid's Tale's Turn Was Great, But What Does It Mean For The Testaments? - Screen Rant

"Wicked, Godless Men": Aunt Lydia's Handmaid's Tale's Turn Was Great, But What Does It Mean For The Testaments? Screen Rant

Published on 22 May 2025 | 5:30 pm

Bros Are Totally Oblivious to Gilead in SNL’s Genius Handmaid’s Tale Parody - NBC

Bros Are Totally Oblivious to Gilead in SNL’s Genius Handmaid’s Tale Parody NBC

Published on 22 May 2025 | 5:04 pm

Gilead to shell out $10M for HBV, HIV programmes from partner HOOKIPA - FirstWord Pharma

Gilead to shell out $10M for HBV, HIV programmes from partner HOOKIPA FirstWord Pharma

Published on 22 May 2025 | 4:47 pm

Gilead Sciences to Acquire HOOKIPA Pharma Assets for $10M - GuruFocus

Gilead Sciences to Acquire HOOKIPA Pharma Assets for $10M GuruFocus

Published on 22 May 2025 | 2:56 pm

Hookipa stock gains as Gilead eyes assets (HOOK:NASDAQ) - Seeking Alpha

Hookipa stock gains as Gilead eyes assets (HOOK:NASDAQ) Seeking Alpha

Published on 22 May 2025 | 2:41 pm

Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs - Fierce Biotech

Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs Fierce Biotech

Published on 22 May 2025 | 2:10 pm

Hookipa Pharma Sells Assets to Gilead Sciences - TipRanks

Hookipa Pharma Sells Assets to Gilead Sciences TipRanks

Published on 22 May 2025 | 12:33 pm

Cromwell pays 'excessive' $1.4 million in attorney fees for Gilead men's home suit, officials say - The Middletown Press

Cromwell pays 'excessive' $1.4 million in attorney fees for Gilead men's home suit, officials say The Middletown Press

Published on 22 May 2025 | 9:26 am

What Analysts Are Saying About Gilead Sciences Stock - Benzinga

What Analysts Are Saying About Gilead Sciences Stock Benzinga

Published on 21 May 2025 | 8:00 pm

Why Serena Joy Told June About The Gilead Commanders In The Handmaid's Tale Season 6, Episode 9 - Screen Rant

Why Serena Joy Told June About The Gilead Commanders In The Handmaid's Tale Season 6, Episode 9 Screen Rant

Published on 21 May 2025 | 4:40 pm

Here's Why Gilead Sciences (GILD) is a Strong Value Stock - Yahoo Finance

Here's Why Gilead Sciences (GILD) is a Strong Value Stock Yahoo Finance

Published on 21 May 2025 | 1:40 pm

Gilead Sciences (GILD) Receives Hold Rating from Needham | GILD Stock News - GuruFocus

Gilead Sciences (GILD) Receives Hold Rating from Needham | GILD Stock News GuruFocus

Published on 21 May 2025 | 11:39 am

'The Handmaid’s Tale' Delivers an Explosive, Tragic Twist in the Penultimate Episode - ELLE

'The Handmaid’s Tale' Delivers an Explosive, Tragic Twist in the Penultimate Episode ELLE

Published on 20 May 2025 | 10:00 pm

Tomas Cihlar, Gilead Sciences, Named to TIME’s List of 100 Most Influential People in the World for HIV Research - ACCESS Newswire

Tomas Cihlar, Gilead Sciences, Named to TIME’s List of 100 Most Influential People in the World for HIV Research ACCESS Newswire

Published on 20 May 2025 | 1:03 pm

What Are The Eyes In 'The Handmaid’s Tale'? The Reason Gilead's Secret Police Are Integral To The Final Series - ELLE

What Are The Eyes In 'The Handmaid’s Tale'? The Reason Gilead's Secret Police Are Integral To The Final Series ELLE

Published on 20 May 2025 | 9:37 am

‘The Testaments’: How Aunt Lydia Will Change in ‘The Handmaid’s Tale’ Spinoff - TV Insider

‘The Testaments’: How Aunt Lydia Will Change in ‘The Handmaid’s Tale’ Spinoff TV Insider

Published on 20 May 2025 | 7:00 am

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch

Gilead Sciences Inc. stock outperforms competitors on strong trading day MarketWatch

Published on 19 May 2025 | 8:30 pm

Unusual Options Alert: The Smart Money Is Piling Into Gilead Sciences (GILD) - Barchart.com

Unusual Options Alert: The Smart Money Is Piling Into Gilead Sciences (GILD) Barchart.com

Published on 19 May 2025 | 5:30 pm

Gilead Sciences: Buy Rating Affirmed Amid Promising Lenacapavir Approval and Market Expansion - TipRanks

Gilead Sciences: Buy Rating Affirmed Amid Promising Lenacapavir Approval and Market Expansion TipRanks

Published on 19 May 2025 | 2:35 pm

Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA - Yahoo Finance

Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA Yahoo Finance

Published on 18 May 2025 | 7:26 pm

Opinion | Is this Gilead? Nope, just Georgia. - The Washington Post

Opinion | Is this Gilead? Nope, just Georgia. The Washington Post

Published on 16 May 2025 | 6:45 pm

Why June's Journey In Gilead Won't End In Season 6 Of 'The Handmaid's Tale' - ELLE

Why June's Journey In Gilead Won't End In Season 6 Of 'The Handmaid's Tale' ELLE

Published on 14 May 2025 | 7:00 am

Top Analyst Reports for Walt Disney, Gilead Sciences & Eaton - Yahoo Finance

Top Analyst Reports for Walt Disney, Gilead Sciences & Eaton Yahoo Finance

Published on 9 May 2025 | 7:00 am

Gilead Pumps $11B More Into US Manufacturing, Hopes To Add 3,000 Jobs - BioSpace

Gilead Pumps $11B More Into US Manufacturing, Hopes To Add 3,000 Jobs BioSpace

Published on 8 May 2025 | 7:00 am

Gilead, bracing for tariffs, joins peers in US drug production push - BioPharma Dive

Gilead, bracing for tariffs, joins peers in US drug production push BioPharma Dive

Published on 8 May 2025 | 7:00 am

Gilead reports final outcomes from trial of bulevirtide for chronic HDV - Clinical Trials Arena

Gilead reports final outcomes from trial of bulevirtide for chronic HDV Clinical Trials Arena

Published on 8 May 2025 | 7:00 am

Gilead tees up $11B in new US manufacturing, R&D investments - Fierce Pharma

Gilead tees up $11B in new US manufacturing, R&D investments Fierce Pharma

Published on 8 May 2025 | 7:00 am

Gilead boosts planned US investments by $11 billion amid tariff threat - Reuters

Gilead boosts planned US investments by $11 billion amid tariff threat Reuters

Published on 7 May 2025 | 7:00 am

Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks - Reuters

Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks Reuters

Published on 29 April 2025 | 7:00 am

Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe - Fierce Pharma

Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe Fierce Pharma

Published on 29 April 2025 | 7:00 am

Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions - CNBC

Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions CNBC

Published on 29 April 2025 | 7:00 am

Gilead Sciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

Gilead Sciences First Quarter 2025 Earnings: Misses Expectations Yahoo Finance

Published on 26 April 2025 | 7:00 am

Gilead, 'closely attuned to' potential US policy shifts, stands by long-acting PrEP launch - Fierce Pharma

Gilead, 'closely attuned to' potential US policy shifts, stands by long-acting PrEP launch Fierce Pharma

Published on 25 April 2025 | 7:00 am

Gilead Dives As Its Biggest Moneymaker Misses. Here's Why It Could Still Be A 'Safe Haven' Stock. - Investor's Business Daily

Gilead Dives As Its Biggest Moneymaker Misses. Here's Why It Could Still Be A 'Safe Haven' Stock. Investor's Business Daily

Published on 25 April 2025 | 7:00 am

Gilead Sciences Earnings Were Solid. How the S&P 500’s No. 1 Health Stock Did. - Barron's

Gilead Sciences Earnings Were Solid. How the S&P 500’s No. 1 Health Stock Did. Barron's

Published on 25 April 2025 | 7:00 am

Gilead leans on HIV drugs as oncology sales slow - BioPharma Dive

Gilead leans on HIV drugs as oncology sales slow BioPharma Dive

Published on 25 April 2025 | 7:00 am

Gilead posts profit, says HIV prevention drug on track for mid-June - Reuters

Gilead posts profit, says HIV prevention drug on track for mid-June Reuters

Published on 24 April 2025 | 7:00 am

Gilead Sciences Announces First Quarter 2025 Financial Results - Business Wire

Gilead Sciences Announces First Quarter 2025 Financial Results Business Wire

Published on 24 April 2025 | 7:00 am

Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type - Reuters

Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type Reuters

Published on 21 April 2025 | 7:00 am

Gilead says its therapy delayed growth of tumors in aggressive form of breast cancer - statnews.com

Gilead says its therapy delayed growth of tumors in aggressive form of breast cancer statnews.com

Published on 21 April 2025 | 7:00 am

Gilead's Trodelvy-Keytruda proposal hits goal in first-line triple-negative breast cancer - Fierce Pharma

Gilead's Trodelvy-Keytruda proposal hits goal in first-line triple-negative breast cancer Fierce Pharma

Published on 21 April 2025 | 7:00 am

Gilead reprimanded after PMCPA finds conference Wi-Fi sponsorship broke advertising rules - Fierce Pharma

Gilead reprimanded after PMCPA finds conference Wi-Fi sponsorship broke advertising rules Fierce Pharma

Published on 14 April 2025 | 7:00 am

Revenue of Gilead Sciences from 2006 to 2024 - Statista

Revenue of Gilead Sciences from 2006 to 2024 Statista

Published on 2 April 2025 | 7:00 am

Potential federal budget cuts won't rock Gilead's HIV boat too much: analysts - Fierce Pharma

Potential federal budget cuts won't rock Gilead's HIV boat too much: analysts Fierce Pharma

Published on 26 March 2025 | 7:00 am

Gilead encouraged by data on once-yearly lenacapavir for HIV prevention - Healio

Gilead encouraged by data on once-yearly lenacapavir for HIV prevention Healio

Published on 14 March 2025 | 7:00 am

Gilead's Once Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study - Contagion Live

Gilead's Once Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study Contagion Live

Published on 11 March 2025 | 7:00 am

Buy Gilead Sciences (GILD) Stock at 52-Week Highs? - Yahoo Finance

Buy Gilead Sciences (GILD) Stock at 52-Week Highs? Yahoo Finance

Published on 8 March 2025 | 8:00 am

Advancing Oncology Care Through Gilead's Research Scholars Program - Gilead Sciences

Advancing Oncology Care Through Gilead's Research Scholars Program Gilead Sciences

Published on 5 March 2025 | 8:00 am

Gilead Sciences sets aside $200 million to resolve HIV drug probe - Reuters

Gilead Sciences sets aside $200 million to resolve HIV drug probe Reuters

Published on 3 March 2025 | 8:00 am

Anticipating Approval, Gilead Gears Up for Mid-Year Launch for Lenacapavir PrEP - BioSpace

Anticipating Approval, Gilead Gears Up for Mid-Year Launch for Lenacapavir PrEP BioSpace

Published on 12 February 2025 | 8:00 am

Gilead provides upbeat 2025 forecast, shares rise 4% - Reuters

Gilead provides upbeat 2025 forecast, shares rise 4% Reuters

Published on 11 February 2025 | 8:00 am

Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV - Gilead Sciences

Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV Gilead Sciences

Published on 5 February 2025 | 8:00 am

Cognizant, Gilead Sciences extend partnership for genAI - MobiHealthNews

Cognizant, Gilead Sciences extend partnership for genAI MobiHealthNews

Published on 31 January 2025 | 8:00 am

Latham & Watkins Advises LEO Pharma in Strategic Partnership With Gilead Sciences - Latham & Watkins LLP

Latham & Watkins Advises LEO Pharma in Strategic Partnership With Gilead Sciences Latham & Watkins LLP

Published on 13 January 2025 | 8:00 am

Dietmar Berger, MD, PhD - Gilead Sciences

Dietmar Berger, MD, PhD Gilead Sciences

Published on 2 January 2025 | 3:52 am

2024 Gilead Oncology Grant Recipients - Gilead Sciences

2024 Gilead Oncology Grant Recipients Gilead Sciences

Published on 26 November 2024 | 5:54 am

TDF Litigation - Gilead Sciences

TDF Litigation Gilead Sciences

Published on 12 November 2024 | 8:40 am

Gilead Helps Pen a Children’s Book for Families Facing Breast Cancer - Gilead Sciences

Gilead Helps Pen a Children’s Book for Families Facing Breast Cancer Gilead Sciences

Published on 14 October 2024 | 7:00 am

Research Scholars Program - Gilead Sciences

Research Scholars Program Gilead Sciences

Published on 26 September 2024 | 10:10 pm

Gilead Foundation: Creating Possible Fund - Gilead Sciences

Gilead Foundation: Creating Possible Fund Gilead Sciences

Published on 18 September 2024 | 7:41 am

Gilead Sciences Medication Access Programs - Gilead Sciences

Gilead Sciences Medication Access Programs Gilead Sciences

Published on 18 September 2024 | 7:41 am

Corporate Giving at Gilead Sciences - Gilead Sciences

Corporate Giving at Gilead Sciences Gilead Sciences

Published on 18 September 2024 | 7:41 am

Giving in North America - Gilead Sciences

Giving in North America Gilead Sciences

Published on 18 September 2024 | 7:39 am

Targeting COVID-19 and Emerging Viruses - Gilead Sciences

Targeting COVID-19 and Emerging Viruses Gilead Sciences

Published on 18 September 2024 | 7:39 am

Ethics and Compliance - Gilead Sciences

Ethics and Compliance Gilead Sciences

Published on 18 September 2024 | 7:26 am